Leading provider of high-quality, system-critical elastomer components
With recognized core competencies in solution design, material know-how and product industrialization, we are a strategic engineering partner for innovative systems in Healthcare, Transportation & Electronics, General Industry and Food & Beverage. Read more about us.
Softpulse
Boosting your wearable application to the next level with SoftPulse®
Soft dry electrodes can be used for easy, comfortable, and long-term monitoring of bio-signals like EEG, ECG, EMG and EOG for consumer as well as medical applications.
Prefilled Syringes
NeoFlex™ Plungers: Superior Drug Delivery Solutions
Datwyler’s NeoFlex™ Plungers: The Reliable Choice for Prefilled Syringes and Cartridges. Our premium plungers offer superior performance and compliance for self-administration devices, meeting the highest industry standards.
Electro Active Polymers (EAP)
Advanced manufacturing of a novel actuation technology
Actuators are mechanical components that allow the transformation of electrical energy into mechanical energy and enable a multipurpose and efficient operation.
Latest news
Datwyler announces changes to its Executive Board in order to strengthen its organization and set a clear course for the future.
The 68th Annual General Meeting of Dätwyler Holding Inc. was held in Altdorf on Tuesday, 17 March 2026. Share-holders approved all Board proposals by a large majority.
Datwyler has successfully completed the acquisition of a majority stake in Capsul’in as announced in December 2025.
In the 2025 financial year, Datwyler generated revenue of CHF 1’100.5 million. Adjusted for negative currency effects of -3.7%, the company achieved organic growth of 3.1%. Due to these currency effects, reported revenue was overall 0.6% below the prior-year level.
Datwyler has received validation of its short-term, Group-wide greenhouse gas reduction targets by the Science Based Targets initiative (SBTi).
Billions of syringes worldwide contain Datwyler components. We are global number two for Sealing Solutions for Parenteral Medicines & Medical Devices.
Sustainability
Plan for solar panels at the Indian plant (2021)
Use of solar panels to generate electricity will help reduce intake from the public power grid. Supply of more than 2’100 MWh of electricity per year. Reduction of CO(sub:2) emission by some 1’800 tons per year. Second phase with solar panels on roof of new building (2022) will add another 2’500 MWh of electricitiy and reduce CO(sub:2)-emissions by another 2’200 tons.
Plan for solar panels at Datwyler plant in Kesurdi, India
Fostering a quality mind-set
Employee Spotlight
Constantly working on better solutions
After more than 20 years at the company, I am proud to say I still feel very motivated to continue my work and provide our customers with better solutions for the future.
Agna Francis
Head of Material Development Healthcare
Sustainability
Exhaust air purification system at Chinese plant
Exhaust air purification system at Datwyler plant in Ningguo, China
Upcoming Events
San Diego, CA, USA
